The aspects presented herein provide fragrance compositions having an olfacive profile that changes with time, wherein the fragrance compositions comprise at least two contrasting perfume accords that provide an olfactory modulating effect, wherein the perfume formulation delivers a desirable scent with increased perceived intensity and improved longevity of perception.

The present application relates to antiperspirant compositions comprising nitrogen-based and/or oxygen based perfume raw materials, and methods for making and using the antiperspirant compositions.

The present disclosure is directed to a class of fluorinated copolymers, such as a PTFE copolymers, that can be dissolved in low toxicity solvents, such as Class III Solvents, and that enable the creation of stable water-in-solvent emulsions comprising the fluorinated copolymers dissolved in a low toxicity solvents and a hydrophilic agent (e.g., a therapeutic agent) dissolved in an aqueous solvent, such as water or saline.

Disclosed is a sunscreen composition that includes a sunscreen active composition, a volatile, oil phase solvent, and a rheology-modifying ethylene copolymer. The sunscreen composition is in the form of a thixotropic gel. The sunscreen composition may be dispersed to the skin using an aerosol- or non-aerosol-based spray apparatus. The sunscreen composition is provided to prevent ultraviolet radiation from causing damage to skin. Methods for preparing a sunscreen composition are also disclosed.

A compound is provided of Formula (I), wherein R.sup.1 represents a C.sub.3 to C.sub.20 hydrocarbon group derived from an alcohol of formula R.sup.1OH, from a formate of formula R.sup.1OCH═O, or a cinnamyl aldehyde of Formula (II) wherein a compound of Formula I is capable of releasing a compound, when oxidized, selected from the group consisting of a fragrant alcohol of formula R.sup.1OH, a fragrant formate ester of formula R.sup.1OCH=0 and aryl aldehyde of Formula (III), wherein R.sup.2 is, independently, hydrogen atom, hydroxyl group, optionally substituted C.sub.1-C.sub.6 alkyl group, C.sub.1-C.sub.6 alkoxy group, or -0(C=0)CH(CH3).sub.2 wherein any two of R.sup.2 may form an optionally substituted 5 or 6 membered ring. The compounds are useful for example as a precursor for the prolonged delivery or release of fragrant compounds such as fragrant alcohols, fragrant aldehydes or fragrant formates. ##STR00001##

The present invention relates to a composition comprising one or more cationic surfactants, one or more amphoteric or zwitterionic surfactants, one or more silicones, one or more cationic polymers, one or more fatty alcohols and one or more clays. The invention also relates to a cosmetic process for washing keratin fibres using this composition. Finally, the invention relates to the use of such a composition for washing keratin fibres.

Described herein are compositions and methods for preventing and/or treating diseases involving aberrant angiogenesis employing one or more benzo[c]chromen-6-one derivatives.

The present invention relates to a composition, for inhibiting dental erosion, and the use thereof. The composition comprises an aqueous solution of hydrofluoric acid, in which the concentration of hydrofluoric acid is 0.05%-2.00% and the pH is between 2.5 and 4.5.

Compositions and methods are provided for a post-procedure care following the treatment of skin with cosmetic skin resurfacing treatments, which include without limitation a variety of laser treatments, chemical peeling and dermabrasion, by applying a silicone-based gel formulation in combination with therapeutic peptides. Peptides of interest include one or more of transforming growth factor, epidermal growth factor, and basic fibroblast growth factor. The formulation may further comprise an effective dose of one or more acylated peptides, which peptides are active in remodeling of the skin.

A method for skin care and/or maintenance including applying or administering a preparation to a subject is provided. The preparation includes a biomedical composition, and the biomedical composition includes an effective amount of micelle, wherein the micelle includes a hyaluronic acid and/or a derivative thereof and a modified histidine. The modified histidine is grafted to at least one primary hydroxyl group of the hyaluronic acid and/or the derivative thereof, and a graft ratio of the modified histidine is 1-100%. Moreover, the hyaluronic acid and/or the derivative thereof and the modified histidine form the micelle on a weight percentage of 0.2-300:1.